InVision Medical Technology
New accelerator entry · 2022-08-26 · the record
In their words
At InVision, we use AI to help streamline the interpretation of ultrasounds and identify diseases that may have been missed by human readers. Our models have been tightly integrated into the clinical workflow to allow easy usage by clinicians. Our work has previously been peer-reviewed and published in several top medical venues, including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), JAMA Cardiology (2022). Results from our blinded and randomized clinical trial on evaluating cardiac function have also been recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology.
What the record says
The full profile
Source Check, INVEST, RECRUIT and Press Requests on InVision Medical Technology
- Source Check — verify what InVision Medical Technology states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with InVision Medical Technology for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist InVision Medical TechnologyYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind InVision Medical Technology: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.